Correction to Lancet Oncol 2021; 22: 1250-64

No authors listed

Free article

Published Erratum

No authors listed. Lancet Oncol. 2022 May.

Free article

. 2022 May;23(5):e207.

doi: 10.1016/S1470-2045(22)00207-8.

No abstract available

Erratum for

Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial.
de Bono JS, Mehra N, Scagliotti GV, Castro E, Dorff T, Stirling A, Stenzl A, Fleming MT, Higano CS, Saad F, Buttigliero C, van Oort IM, Laird AD, Mata M, Chen HC, Healy CG, Czibere A, Fizazi K. de Bono JS, et al. Lancet Oncol. 2021 Sep;22(9):1250-1264. doi: 10.1016/S1470-2045(21)00376-4. Epub 2021 Aug 10. Lancet Oncol. 2021. PMID: 34388386 Clinical Trial.